These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15231394)

  • 1. Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus.
    Wang Y; Chong OT; Yuan Y
    Virology; 2004 Jul; 325(1):149-63. PubMed ID: 15231394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.
    Seaman WT; Ye D; Wang RX; Hale EE; Weisse M; Quinlivan EB
    Virology; 1999 Oct; 263(2):436-49. PubMed ID: 10544116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
    Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
    J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.
    Lefort S; Soucy-Faulkner A; Grandvaux N; Flamand L
    J Virol; 2007 Oct; 81(20):10950-60. PubMed ID: 17652396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
    Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.
    Wang Y; Yuan Y
    Virology; 2007 Mar; 359(1):19-27. PubMed ID: 17055026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
    Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
    J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus.
    Wang XP; Zhang YJ; Deng JH; Pan HY; Zhou FC; Montalvo EA; Gao SJ
    Oncogene; 2001 Jan; 20(4):523-30. PubMed ID: 11313983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
    Staudt MR; Dittmer DP
    Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
    Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
    J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence.
    Wang S; Liu S; Wu M; Geng Y; Wood C
    Arch Virol; 2001 Jul; 146(7):1415-26. PubMed ID: 11556717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
    Bowser BS; Morris S; Song MJ; Sun R; Damania B
    Virology; 2006 May; 348(2):309-27. PubMed ID: 16546233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11.
    Chen L; Park MS
    Virus Res; 2009 Jun; 142(1-2):160-8. PubMed ID: 19428749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
    Xu Y; AuCoin DP; Huete AR; Cei SA; Hanson LJ; Pari GS
    J Virol; 2005 Mar; 79(6):3479-87. PubMed ID: 15731242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lytic cycle switches of oncogenic human gammaherpesviruses.
    Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
    Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
    Harrison SM; Whitehouse A
    FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.